Patents Assigned to AB2 BIO SA
  • Patent number: 11926663
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: March 12, 2024
    Assignee: AB2 BIO SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • Patent number: 11820817
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: November 21, 2023
    Assignee: AB2 Bio SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • Patent number: 11530263
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: December 20, 2022
    Assignee: AB2 Bio SA
    Inventors: Andrea Pfeifer, Greg Del Val
  • Patent number: 10882905
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: January 5, 2021
    Assignee: AB2 BIO SA
    Inventors: Greg Del Val, Eduardo Schiffrin
  • Patent number: 10858426
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the indications.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: December 8, 2020
    Assignee: AB2 BIO SA
    Inventors: Andrea Pfeifer, Greg Del Val
  • Publication number: 20200377586
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders. In particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 3, 2020
    Applicant: AB2 BIO SA
    Inventors: Greg DEL VAL, Eduardo SCHIFFRIN
  • Publication number: 20180127494
    Abstract: The present invention provides means and methods for treating Interleukin 18 (IL-18)-associated diseases and disorders, in particular, the present invention discloses antibodies specific for free IL-18 and IL-18 Binding Protein (IL-18BP) for use in such treatments and for the diagnosis of the diseases and disorders.
    Type: Application
    Filed: March 3, 2016
    Publication date: May 10, 2018
    Applicant: AB2 BIO SA
    Inventors: Greg DEL VAL, Eduardo SCHIFFRIN